These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2737760

  • 1. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
    Sun ZM, Maskell JP, Sehgal SC, Williams JD.
    Infection; 1989; 17(3):165-7. PubMed ID: 2737760
    [Abstract] [Full Text] [Related]

  • 2. Lomefloxacin: microbiologic assessment and unique properties.
    Mayer KH, Ellal JA.
    Am J Med; 1992 Apr 06; 92(4A):58S-62S. PubMed ID: 1316073
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991 Apr 06; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 4. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug 06; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN.
    Diagn Microbiol Infect Dis; 1989 Aug 06; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [Abstract] [Full Text] [Related]

  • 6. In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
    Debbia EA, Pesce A, Schito GC.
    Am J Med; 1992 Apr 06; 92(4A):45S-47S. PubMed ID: 1316070
    [Abstract] [Full Text] [Related]

  • 7. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Apr 06; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
    Molinari G, Bandelloni R, Paglia P, Debbia E, Schito GC.
    Diagn Microbiol Infect Dis; 1989 Apr 06; 12(3 Suppl):53S-56S. PubMed ID: 2791499
    [Abstract] [Full Text] [Related]

  • 15. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN, Sarachian B, Fernandez A, Paolasso R, Kaufman C, Notario R, Porven G, Ingaramo RA, Perez S, Ferrero SM.
    Diagn Microbiol Infect Dis; 1989 Apr 06; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 Apr 06; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 18. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Sep 06; 40(3):427-31. PubMed ID: 9338498
    [Abstract] [Full Text] [Related]

  • 19. The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
    Thomson KS, Sanders CC.
    J Antimicrob Chemother; 1998 Aug 06; 42(2):179-87. PubMed ID: 9738835
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.